Email updates

Keep up to date with the latest news and content from BMC Nephrology and BioMed Central.

Open Access Research article

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China

Weibo Le1, Cai-Hong Zeng1, Zhangsuo Liu2, Dong Liu2, Qing Yang3, Rui-Xia Lin3, Zheng-Kun Xia4, Zhong-Min Fan4, Guanghua Zhu5, Ying Wu5, Hong Xu6, Yihui Zhai6, Ying Ding7, Xiaoqing Yang7, Shaoshan Liang1, Hao Chen1, Feng Xu1, Qian Huang1, Hongbing Shen8, Jianming Wang8, Agnes B Fogo9* and Zhi-Hong Liu1*

Author Affiliations

1 Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

2 Department of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

3 Department of Nephrology, Yuying Children’s Hospital Affiliated to Wenzhou Medical College, Wenzhou, Zhejiang, China

4 Department of Pediatrics, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

5 Department of Nephrology and Rheumatology, Children’s Hospital of Shanghai Jiaotong University, Shanghai, China

6 Department of Nephrology and Rheumatology, Children’s Hospital of Fudan University, Shanghai, China

7 Department of Pediatrics, The first affiliated hospital of henan college of TCM, Zhengzhou, China

8 Department of Epidemiology and Biostatistics & Ministry of Education Key Lab for Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

9 Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA

For all author emails, please log on.

BMC Nephrology 2012, 13:158  doi:10.1186/1471-2369-13-158

Published: 27 November 2012



The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.


A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study.


There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04).


We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN.

Glomerulonephritis; IgA nephropathy; Oxford classification; Children; Pediatrics